相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH)
Soodabeh Sarafrazi et al.
HUMAN MUTATION (2022)
Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia
Rocio Fuente et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program
Eric T. Rush et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis
Xiawen Yu et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Dramatic Transformation After Burosumab in a Young Boy With X-linked Hypophosphatemia: A Life-Changing Saga
Krishna Baradhi
CUREUS JOURNAL OF MEDICAL SCIENCE (2022)
X-linked hypophosphatemia: The medical expert's challenges and the patient's concerns on their journey with the disease
Neveen A. T. Hamdy et al.
ARCHIVES DE PEDIATRIE (2021)
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Raja Padidela et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling
Yasuki Ishihara et al.
BONE (2021)
Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
Franz Ewendt et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
Enrique Rodriguez-Rubio et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia
Axelle Cauliez et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease
Anna Kurpas et al.
DISEASE MARKERS (2021)
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
Michael R. Laurent et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management
Giampiero Igli Baroncelli et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
X-Linked Hypophosphataemic Rickets and Growth
Fernando Santos Rodriguez
ADVANCES IN THERAPY (2020)
Functional Characterization of PHEX Gene Variants in Children With X-Linked Hypophosphatemic Rickets Shows No Evidence of Genotype-Phenotype Correlation
Bixia Zheng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Forough Saki et al.
BMC NEPHROLOGY (2020)
A novel c.2179T>C mutation blocked the intracellular transport of PHEX protein and caused X-linked hypophosphatemic rickets in a Chinese family
Baowei Li et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
An Overview of Rickets in Children
Rahul Chanchlani et al.
KIDNEY INTERNATIONAL REPORTS (2020)
New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
Maria L. Mace et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives
Adalbert Raimann et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2020)
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck-Nielsen et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia
Cong Zhang et al.
BONE (2019)
Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score
Tom D. Thacher et al.
BONE (2019)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
Michael P. Whyte et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
First-in-Asian Phase I Study of the Anti-Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X-linked Hypophosphatemia
Hae Il Cheong et al.
JBMR PLUS (2019)
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Yuka Kinoshita et al.
ENDOCRINE REVIEWS (2018)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations
Douglas Chesher et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Marked alterations in the structure, dynamics and maturation of growth plate likely explain growth retardation and bone deformities of young Hyp mice
Rocio Fuente et al.
BONE (2018)
Phosphate Homeostasis, Inflammation and the Regulation of FGF-23
Florian Lang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse
Ichiro Kaneko et al.
ENDOCRINOLOGY (2018)
Rickets
Thomas O. Carpenter et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Outcomes of orthopedic surgery in a cohort of 49 patients with X-linked hypophosphatemic rickets (XLHR)
A. Gizard et al.
ENDOCRINE CONNECTIONS (2017)
Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications
Silje Rafaelsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
Sathish K. Murali et al.
PLOS BIOLOGY (2016)
Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets
Nurul Nadirah Razali et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2015)
Eldecalcitol reduces osteoporotic fractures by unique mechanisms
Satoshi Kondo et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Contemporary Medical and Surgical Management of X-linked Hypophosphatemic Rickets
Melinda S. Sharkey et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2015)
Hypophosphatemic rickets: etiology, clinical features and treatment
Vito Pavone et al.
European Journal of Orthopaedic Surgery and Traumatology (2014)
Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia
Nilana M. T. Barros et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type
Marcos Morey et al.
BMC MEDICAL GENETICS (2011)
A Clinician's Guide to X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets
Miroslav Zivicnjak et al.
PEDIATRIC NEPHROLOGY (2011)
Phenotype Presentation of Hypophosphatemic Rickets in Adults
Signe S. Beck-Nielsen et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark
Signe Sparre Beck-Nielsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets
Celine Gaucher et al.
HUMAN GENETICS (2009)
Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX gene
Polyzois Makras et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets
Hae-Ryong Song et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
How fibroblast growth factor 23 works
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mineralized tissue cells are a principal source of FGF23
Yuji Yoshiko et al.
BONE (2007)
Evaluation of stature development during childhood and adolescence in individuals with familial hypophosphatemic rickets
Mauro M. S. Borghi et al.
THESCIENTIFICWORLDJOURNAL (2005)
A clinical and molecular genetic study of hypophosphatemic rickets in children
HY Cho et al.
PEDIATRIC RESEARCH (2005)
Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes
Y Sabbagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis
C Qin et al.
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2004)
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets
O Mäkitie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
LD Quarles
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Structure and function of disease-causing missense mutations in the PHEX gene
Y Sabbagh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Human fibroblast growth factor-23 mutants suppress Na+ -dependent phosphate co-transport activity and 1α,25-dihydroxyvitamin D3 production
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
T Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
